275 related articles for article (PubMed ID: 27215283)
1. Photoactivation of Diiodido-Pt(IV) Complexes Coupled to Upconverting Nanoparticles.
Perfahl S; Natile MM; Mohamad HS; Helm CA; Schulzke C; Natile G; Bednarski PJ
Mol Pharm; 2016 Jul; 13(7):2346-62. PubMed ID: 27215283
[TBL] [Abstract][Full Text] [Related]
2. An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance.
Ai F; Sun T; Xu Z; Wang Z; Kong W; To MW; Wang F; Zhu G
Dalton Trans; 2016 Aug; 45(33):13052-60. PubMed ID: 27430044
[TBL] [Abstract][Full Text] [Related]
3. Near infrared activation of an anticancer Pt(IV) complex by Tm-doped upconversion nanoparticles.
Ruggiero E; Hernández-Gil J; Mareque-Rivas JC; Salassa L
Chem Commun (Camb); 2015 Feb; 51(11):2091-4. PubMed ID: 25536114
[TBL] [Abstract][Full Text] [Related]
4. Photoactivatable Cell-Selective Dinuclear trans-Diazidoplatinum(IV) Anticancer Prodrugs.
Shi H; Romero-Canelón I; Hreusova M; Novakova O; Venkatesh V; Habtemariam A; Clarkson GJ; Song JI; Brabec V; Sadler PJ
Inorg Chem; 2018 Nov; 57(22):14409-14420. PubMed ID: 30365308
[TBL] [Abstract][Full Text] [Related]
5. Near-infrared light-mediated photoactivation of a platinum antitumor prodrug and simultaneous cellular apoptosis imaging by upconversion-luminescent nanoparticles.
Min Y; Li J; Liu F; Yeow EK; Xing B
Angew Chem Int Ed Engl; 2014 Jan; 53(4):1012-6. PubMed ID: 24311528
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and X-ray crystal structure of trans,cis-[Pt(OAc)2I2(en)]: a novel type of cisplatin analog that can be photolyzed by visible light to DNA-binding and cytotoxic species in vitro.
Kratochwil NA; Zabel M; Range KJ; Bednarski PJ
J Med Chem; 1996 Jun; 39(13):2499-507. PubMed ID: 8691447
[TBL] [Abstract][Full Text] [Related]
7. Photosensitive Pt(IV)-azide prodrug-loaded nanoparticles exhibit controlled drug release and enhanced efficacy in vivo.
Xiao H; Noble GT; Stefanick JF; Qi R; Kiziltepe T; Jing X; Bilgicer B
J Control Release; 2014 Jan; 173():11-7. PubMed ID: 24511610
[TBL] [Abstract][Full Text] [Related]
8. Studies on the photoactivation of two cytotoxic trans,trans,trans-diazidodiaminodihydroxo-Pt(IV) complexes.
Westendorf AF; Bodtke A; Bednarski PJ
Dalton Trans; 2011 May; 40(19):5342-51. PubMed ID: 21461431
[TBL] [Abstract][Full Text] [Related]
9. Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs.
Ravera M; Perin E; Gabano E; Zanellato I; Panzarasa G; Sparnacci K; Laus M; Osella D
J Inorg Biochem; 2015 Oct; 151():132-42. PubMed ID: 26277416
[TBL] [Abstract][Full Text] [Related]
10. Diazido mixed-amine platinum(IV) anticancer complexes activatable by visible-light form novel DNA adducts.
Zhao Y; Woods JA; Farrer NJ; Robinson KS; Pracharova J; Kasparkova J; Novakova O; Li H; Salassa L; Pizarro AM; Clarkson GJ; Song L; Brabec V; Sadler PJ
Chemistry; 2013 Jul; 19(29):9578-91. PubMed ID: 23733242
[TBL] [Abstract][Full Text] [Related]
11. Photoactivatable platinum complexes.
Bednarski PJ; Mackay FS; Sadler PJ
Anticancer Agents Med Chem; 2007 Jan; 7(1):75-93. PubMed ID: 17266506
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional Liposome Nanocarriers Combining Upconverting Nanoparticles and Anticancer Drugs.
Huang Y; Hemmer E; Rosei F; Vetrone F
J Phys Chem B; 2016 Jun; 120(22):4992-5001. PubMed ID: 27135855
[TBL] [Abstract][Full Text] [Related]
13. Photoactivatable diazido Pt(IV) anticancer complex can bind to and oxidize all four nucleosides.
Cheng Y; Zhang J; Wu K; Gao F; Cheng Y; Zou T; Wu X; Zhao Y; Wang F
Dalton Trans; 2020 Dec; 49(47):17157-17163. PubMed ID: 33244530
[TBL] [Abstract][Full Text] [Related]
14. Near-infrared-triggered anticancer drug release from upconverting nanoparticles.
Fedoryshin LL; Tavares AJ; Petryayeva E; Doughan S; Krull UJ
ACS Appl Mater Interfaces; 2014 Aug; 6(16):13600-6. PubMed ID: 25090028
[TBL] [Abstract][Full Text] [Related]
15. Charge convertibility and near infrared photon co-enhanced cisplatin chemotherapy based on upconversion nanoplatform.
Xu J; Kuang Y; Lv R; Yang P; Li C; Bi H; Liu B; Yang D; Dai Y; Gai S; He F; Xing B; Lin J
Biomaterials; 2017 Jun; 130():42-55. PubMed ID: 28364630
[TBL] [Abstract][Full Text] [Related]
16. Real-time, non-invasive monitoring of hydrogel degradation using LiYF4:Yb(3+)/Tm(3+) NIR-to-NIR upconverting nanoparticles.
Jalani G; Naccache R; Rosenzweig DH; Lerouge S; Haglund L; Vetrone F; Cerruti M
Nanoscale; 2015 Jul; 7(26):11255-62. PubMed ID: 26067274
[TBL] [Abstract][Full Text] [Related]
17. Human transport protein carrier for controlled photoactivation of antitumor prodrug and real-time intracellular tumor imaging.
Li X; Mu J; Liu F; Tan EW; Khezri B; Webster RD; Yeow EK; Xing B
Bioconjug Chem; 2015 May; 26(5):955-61. PubMed ID: 25938732
[TBL] [Abstract][Full Text] [Related]
18. 796 nm Activation of a Photocleavable Ruthenium(II) Complex Conjugated to an Upconverting Nanoparticle through Two Phosphonate Groups.
Meijer MS; Natile MM; Bonnet S
Inorg Chem; 2020 Oct; 59(20):14807-14818. PubMed ID: 32167752
[TBL] [Abstract][Full Text] [Related]
19. Photocytotoxic Pt(iv) complexes as prospective anticancer agents.
Canil G; Braccini S; Marzo T; Marchetti L; Pratesi A; Biver T; Funaioli T; Chiellini F; Hoeschele JD; Gabbiani C
Dalton Trans; 2019 Aug; 48(29):10933-10944. PubMed ID: 31165118
[TBL] [Abstract][Full Text] [Related]
20. Reaction of human telomeric unit TTAGGG and a photoactivatable Pt(IV) anticancer prodrug.
Lin J; Zhang J; Ma Z; Wu X; Wang F; Zhao Y; Wu K; Liu Y
Dalton Trans; 2023 Aug; 52(34):12057-12066. PubMed ID: 37581306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
